Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Niels Søndergaard-Heinrich"'
Autor:
Joana Mendes Lopes de Melo, Jens Christian Laursen, Niels Søndergaard-Heinrich, Ida Kirstine Bull Rasmussen, Christian Stevns Hansen, Marie Frimodt-Møller, Peter Rossing, Joachim Størling
Publikováno v:
Heliyon, Vol 8, Iss 12, Pp e12304- (2022)
Changes in cellular bioenergetics such as mitochondrial respiration and glycolysis may play a role in the pathogenesis of various diseases including type 1 diabetes (T1D). We used Seahorse extracellular flux technology to analyse the efficiency of gl
Externí odkaz:
https://doaj.org/article/447e854525704cb9a0877bf494336f07
Autor:
Jens Christian Laursen, MD, Niels Søndergaard-Heinrich, MD, Joana Mendes Lopes de Melo, PhD, Bryan Haddock, PhD, Ida Kirstine Bull Rasmussen, MD, Farzaneh Safavimanesh, PhD, Christian Stevns Hansen, PhD, Joachim Størling, PhD, Henrik Bo Wiberg Larsson, DMSc, Per-Henrik Groop, DMSc, Marie Frimodt-Møller, PhD, Ulrik Bjørn Andersen, MD, Peter Rossing, DMSc
Publikováno v:
EClinicalMedicine, Vol 37, Iss , Pp 100895- (2021)
Background: Inhibitors of the sodium-glucose cotransporter 2 (SGLT2) slow the progression of diabetic kidney disease, possibly by reducing the proximal tubule transport workload with subsequent improvement of renal oxygenation. We aimed to test this
Externí odkaz:
https://doaj.org/article/138294fdf9f142cf981e146421e9f9ae
Autor:
Mark B. Vestergaard, Jens Christian Laursen, Niels Søndergaard Heinrich, Peter Rossing, Tine Willum Hansen, Henrik B. W. Larsson
Publikováno v:
Frontiers in Neuroscience, Vol 17 (2023)
IntroductionPatients with type 1 diabetes (T1D) demonstrate brain alterations, including white matter lesions and cerebral atrophy. In this case–control study, we investigated if a reason for this atrophy could be because of diabetes-related compli
Externí odkaz:
https://doaj.org/article/95b55858919c457d94d67fcb3e2f64b0
Autor:
Therese Adrian, Mads Hornum, Filip Krag Knop, Thomas Almdal, Peter Rossing, Lisa í Lída, Niels Søndergaard Heinrich, Vincent Oltman Boer, Anouk Marsman, Esben Thade Petersen, Hartwig Roman Siebner, Bo Feldt-Rasmussen
Publikováno v:
Nephron. :1-12
Background: Nonalcoholic fatty liver disease (NAFLD) is suggested as a risk factor for chronic kidney disease (CKD). The incidence of NAFLD is rising globally in parallel to the increasing incidences of obesity and type 2 diabetes. Diabetes remains t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::24646cda431b0c7de6562c29bfd3d3b8
https://doi.org/10.1159/000528080
https://doi.org/10.1159/000528080
Autor:
Niels Søndergaard Heinrich, Margit Kriegbaum, Mia Klinten Grand, Bent Struer Lind, Christen Lykkegaard Andersen, Frederik Persson
Publikováno v:
Primary Care Diabetes. 16:818-823
Primary care plays an integral role in the management of type 2 diabetes (T2D). We investigated in a large group of individuals in this setting the biochemical profiles, pharmacological management and clinical outcomes as well as their changes over t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed77bf5db5b3a7ab31e50125f7845d63
https://doi.org/10.1016/j.pcd.2022.10.006
https://doi.org/10.1016/j.pcd.2022.10.006
Autor:
Susanne Rosthøj, Tobias Bomholt, Bo Feldt-Rasmussen, Niels Søndergaard Heinrich, Filip K. Knop, Linda Hilsted, Mads Hornum, Marianne Rix, Anders Larsson, Thomas Almdal, Morten B. Jørgensen
Publikováno v:
Blood Purification. 51:608-616
Introduction: The accuracy of hemoglobin A1c (HbA1c) as a glycemic marker in patients with type 2 diabetes (T2D) receiving hemodialysis (HD) remains unknown. To assess accuracy, we compared HbA1c and fructosamine levels with interstitial glucose meas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73ba9164699ff8a11d8b22f3b953a608
https://doi.org/10.1159/000519050
https://doi.org/10.1159/000519050
Autor:
Therese Adrian, Mads Hornum, Filip K. Knop, Thomas Peter Almdal, Peter Rossing, Lisa Lida, Niels Søndergaard Heinrich, Vincent Boer, Anouk Marsman, Esben Petersen, Hartwig Siebner, Bo Feldt-Rasmussen
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS Non-alcoholic fatty liver disease (NAFLD) is suggested as being a risk factor for chronic kidney disease (CKD). The incidence of NAFLD is rising globally parallel to the increasing incidences of obesity and type 2 diabetes. As dia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b152936485b12470803d7273f34fb18
https://doi.org/10.1093/ndt/gfac070.022
https://doi.org/10.1093/ndt/gfac070.022
Autor:
Tarunveer S. Ahluwalia, Tine W. Hansen, Jens P. Goetze, Frederik Persson, Jørgen Jeppesen, Simone Theilade, Nete Tofte, Signe Abitz Winther, Niels Søndergaard Heinrich, Peter Rossing
Publikováno v:
Nephrology Dialysis Transplantation. 37:100-107
Background Plasma copeptin is a surrogate of arginine vasopressin (AVP) secretion and is associated with a risk of renal and cardiovascular disease. We investigated associations between copeptin and renal events, cardiovascular events and mortality i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af9194b7bcc20ffe9576e610a718b367
https://doi.org/10.1093/ndt/gfaa308
https://doi.org/10.1093/ndt/gfaa308
Autor:
Joana Melo, Ida K. B. Rasmussen, Jens Laursen, Joachim Størling, Christian Stevns Hansen, Marie Frimodt-Moeller, Peter Rossing, Niels Søndergaard Heinrich
Publikováno v:
Diabetes. 70
Sodium-glucose cotransporter-2 (SGLT2) inhibition is emerging as a beneficial adjunctive therapy in type 1 diabetes (T1D). It is hypothesized that SGLT2 inhibition relieves hypoxia in the kidneys. As mitochondrial dysfunction might contribute to kidn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a377fbac00c4abd694156ad750dd2984
https://doi.org/10.2337/db21-802-p
https://doi.org/10.2337/db21-802-p
Autor:
Joachim Størling, Ulrik B. Andersen, Henrik Larsson, Farzaneh Safavimanesh, Marie Frimodt-Moeller, Bryan Haddock, Joana Melo, Per-Henrik Groop, Christian Stevns Hansen, Peter Rossing, Niels Søndergaard Heinrich, Jens Laursen, Ida K. B. Rasmussen
Publikováno v:
Diabetes. 70
Objective: Inhibitors of the sodium-glucose cotransporter 2 slow the progression of diabetic kidney disease, possibly by reducing the proximal tubule transport workload with subsequent improvement of renal oxygenation. We aimed to test this hypothesi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f2c3745b9ca433adee3c12a25e2760f2
https://doi.org/10.2337/db21-318-or
https://doi.org/10.2337/db21-318-or